403 related articles for article (PubMed ID: 15055137)
21. Voriconazole: therapeutic review of a new azole antifungal.
Herbrecht R
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
[TBL] [Abstract][Full Text] [Related]
22. Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-Nübling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E
Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306
[TBL] [Abstract][Full Text] [Related]
23. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
[TBL] [Abstract][Full Text] [Related]
24. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
25. Torsades de pointes associated with voriconazole use.
Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
[TBL] [Abstract][Full Text] [Related]
26. Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in Intensive Care Unit.
Nataloni S; Gabbanelli V; Rossi R; Donati A; Pantanetti S; Pelaia P
Minerva Anestesiol; 2007 Jun; 73(6):371-5. PubMed ID: 17072284
[TBL] [Abstract][Full Text] [Related]
27. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
[TBL] [Abstract][Full Text] [Related]
28. CNS-aspergillosis: are there new treatment options?
Schwartz S; Thiel E
Mycoses; 2003; 46 Suppl 2():8-14. PubMed ID: 15055138
[TBL] [Abstract][Full Text] [Related]
29. Voriconazole therapy in children with cystic fibrosis.
Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology and clinical use of voriconazole.
Thompson GR; Lewis JS
Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):83-94. PubMed ID: 19947892
[TBL] [Abstract][Full Text] [Related]
31. The safety of voriconazole.
Potoski BA; Brown J
Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
[No Abstract] [Full Text] [Related]
32. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
Steinbach WJ; Benjamin DK; Kontoyiannis DP; Perfect JR; Lutsar I; Marr KA; Lionakis MS; Torres HA; Jafri H; Walsh TJ
Clin Infect Dis; 2004 Jul; 39(2):192-8. PubMed ID: 15307028
[TBL] [Abstract][Full Text] [Related]
33. Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
Herbrecht R
Ann Hematol; 2002; 81 Suppl 2():S52-3. PubMed ID: 12611078
[No Abstract] [Full Text] [Related]
34. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
Kim SH; Yim DS; Choi SM; Kwon JC; Han S; Lee DG; Park C; Kwon EY; Park SH; Choi JH; Yoo JH
Int J Infect Dis; 2011 Nov; 15(11):e753-8. PubMed ID: 21831685
[TBL] [Abstract][Full Text] [Related]
35. Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
Al-Badriyeh D; Heng SC; Neoh CF; Slavin M; Stewart K; Kong DC
Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):623-36. PubMed ID: 21155694
[TBL] [Abstract][Full Text] [Related]
36. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
37. [Voriconazole: a new weapon against invasive fungal infections].
Aoun M
Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
[TBL] [Abstract][Full Text] [Related]
38. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
Cecil JA; Wenzel RP
Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966
[TBL] [Abstract][Full Text] [Related]
39. Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Chow E; Moore T; Nielsen K
Pediatr Infect Dis J; 2003 Dec; 22(12):1109-10. PubMed ID: 14688580
[TBL] [Abstract][Full Text] [Related]
40. Voriconazole: in the treatment of invasive aspergillosis.
Muijsers RB; Goa KL; Scott LJ
Drugs; 2002; 62(18):2655-64; discussion 2665-6. PubMed ID: 12466006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
